Published in Nucleosides Nucleotides Nucleic Acids on May 01, 2009
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med (2001) 5.09
Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci (2002) 2.14
The mechanism of action of S-adenosylhomocysteinase. J Biol Chem (1979) 1.62
Biological effects of inhibitors of S-adenosylhomocysteine hydrolase. Pharmacol Ther (1998) 1.61
Neplanocin A. A potent inhibitor of S-adenosylhomocysteine hydrolase and of vaccinia virus multiplication in mouse L929 cells. J Biol Chem (1984) 1.54
S-adenosyl-L-homocysteine hydrolase as a target for antiviral chemotherapy. J Med Chem (1991) 1.30
Structure and function of S-adenosylhomocysteine hydrolase. Cell Biochem Biophys (2000) 1.29
Crystal structure of S-adenosylhomocysteine hydrolase from rat liver. Biochemistry (1999) 1.27
Chagas disease. Postgrad Med J (2006) 1.25
Catalytic strategy of S-adenosyl-L-homocysteine hydrolase: transition-state stabilization and the avoidance of abortive reactions. Biochemistry (2003) 1.22
The mRNA capping apparatus as drug target and guide to eukaryotic phylogeny. Cold Spring Harb Symp Quant Biol (2001) 1.08
Carbocyclic adenosine analogues as S-adenosylhomocysteine hydrolase inhibitors and antiviral agents: recent advances. Nucleosides Nucleotides (1998) 1.04
Catalytic mechanism of S-adenosylhomocysteine hydrolase. Site-directed mutagenesis of Asp-130, Lys-185, Asp-189, and Asn-190. J Biol Chem (2002) 0.97
Mechanism for enzymatic thioether formation. Mechanism of action of S-adenosylhomocysteinase. J Biol Chem (1976) 0.95
Cloning of the gene encoding Leishmania donovani S-adenosylhomocysteine hydrolase, a potential target for antiparasitic chemotherapy. Mol Biochem Parasitol (1992) 0.95
Trypanosoma cruzi: molecular cloning and characterization of the S-adenosylhomocysteine hydrolase. Exp Parasitol (2003) 0.94
Contributions of active site residues to the partial and overall catalytic activities of human S-adenosylhomocysteine hydrolase. Biochemistry (2002) 0.92
Comparative kinetics of cofactor association and dissociation for the human and trypanosomal S-adenosylhomocysteine hydrolases. 1. Basic features of the association and dissociation processes. Biochemistry (2007) 0.91
Domain motions and the open-to-closed conformational transition of an enzyme: a normal mode analysis of S-adenosyl-L-homocysteine hydrolase. Biochemistry (2005) 0.89
Overexpression, purification, and characterization of S-adenosylhomocysteine hydrolase from Leishmania donovani. Arch Biochem Biophys (2000) 0.86
Comparative kinetics of cofactor association and dissociation for the human and trypanosomal S-adenosylhomocysteine hydrolases. 2. The role of helix 18 stability. Biochemistry (2008) 0.85
Inactivation of S-adenosyl-L-homocysteine hydrolase and antiviral activity with 5',5',6',6'-tetradehydro-6'-deoxy-6'-halohomoadenosine analogues (4'-haloacetylene analogues derived from adenosine). J Med Chem (1998) 0.85
Mutational analyses of Plasmodium falciparum and human S-adenosylhomocysteine hydrolases. Mol Biochem Parasitol (2005) 0.85
The antiviral drug ribavirin is a selective inhibitor of S-adenosyl-L-homocysteine hydrolase from Trypanosoma cruzi. Bioorg Med Chem (2007) 0.84
Effects of ligand binding and oxidation on hinge-bending motions in S-adenosyl-L-homocysteine hydrolase. Biochemistry (2006) 0.83
(E)-5',6'-didehydro-6'-deoxy-6'-fluorohomoadenosine: a substrate that measures the hydrolytic activity of S-adenosylhomocysteine hydrolase. Biochemistry (1994) 0.82
Computational characterization of substrate binding and catalysis in S-adenosylhomocysteine hydrolase. Biochemistry (2001) 0.81
Substrate binding stabilizes S-adenosylhomocysteine hydrolase in a closed conformation. Biochemistry (2000) 0.81
S-adenosylhomocysteine hydrolase. Stereochemistry and kinetics of hydrogen transfer. J Biol Chem (1993) 0.81
Folate, homocysteine, endothelial function and cardiovascular disease. What is the link? Biomed Pharmacother (2001) 0.80
Molecular dynamics simulations of domain motions of substrate-free S-adenosyl- L-homocysteine hydrolase in solution. Proteins (2008) 0.79
Reduced S-adenosylhomocysteine hydrolase. Kinetics and thermodynamics for binding of 3'-ketoadenosine, adenosine, and adenine. J Biol Chem (1992) 0.78
Mechanism of bovine liver S-adenosylhomocysteine hydrolase. Steady-state and pre-steady-state kinetic analysis. J Biol Chem (1991) 0.78
Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality. J Pharm Sci (2009) 2.36
IpaD localizes to the tip of the type III secretion system needle of Shigella flexneri. Infect Immun (2006) 2.24
Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine. Hepatology (2010) 2.10
Nanotechnology in vaccine delivery. Adv Drug Deliv Rev (2008) 1.91
Enzymes involved in the bioconversion of ester-based prodrugs. J Pharm Sci (2006) 1.85
Barriers to nonviral gene delivery. J Pharm Sci (2003) 1.77
Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes. Proc Natl Acad Sci U S A (2008) 1.71
A three-dimensional molecular model of lipid-free apolipoprotein A-I determined by cross-linking/mass spectrometry and sequence threading. Biochemistry (2005) 1.53
Biophysical characterization of PEI/DNA complexes. J Pharm Sci (2003) 1.44
Summary workshop report: biopharmaceutics classification system--implementation challenges and extension opportunities. J Pharm Sci (2004) 1.43
Conformational stability and disassembly of Norwalk virus-like particles. Effect of pH and temperature. J Biol Chem (2006) 1.41
Novel regulators of Fgf23 expression and mineralization in Hyp bone. Mol Endocrinol (2009) 1.34
Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa? Pharm Res (2002) 1.33
Silicone oil induced aggregation of proteins. J Pharm Sci (2005) 1.32
Preparation and characterization of translocator/chaperone complexes and their component proteins from Shigella flexneri. Biochemistry (2007) 1.32
K-Screen: a free application for high throughput screening data analysis, visualization, and laboratory information management. Comb Chem High Throughput Screen (2011) 1.30
Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles. J Pharm Sci (2005) 1.27
Polyanions and the proteome. Mol Cell Proteomics (2004) 1.24
The photo-Favorskii reaction of p-hydroxyphenacyl compounds is initiated by water-assisted, adiabatic extrusion of a triplet biradical. J Am Chem Soc (2008) 1.22
Catalytic strategy of S-adenosyl-L-homocysteine hydrolase: transition-state stabilization and the avoidance of abortive reactions. Biochemistry (2003) 1.22
Derivative absorbance spectroscopy and protein phase diagrams as tools for comprehensive protein characterization: a bGCSF case study. J Pharm Sci (2003) 1.21
Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens. J Biol Chem (2005) 1.19
Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development. Adv Drug Deliv Rev (2011) 1.19
Thermal stability of vaccines. J Pharm Sci (2003) 1.17
Structural stability of adenovirus type 5. J Pharm Sci (2003) 1.17
Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization. J Pharm Sci (2006) 1.17
Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: essential need to use orthogonal methods to assure the quality of therapeutic protein products. J Pharm Sci (2010) 1.16
Structure-function analysis of invasion plasmid antigen C (IpaC) from Shigella flexneri. J Biol Chem (2002) 1.15
Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents. Bioorg Med Chem Lett (2011) 1.14
Physical characterization of MxiH and PrgI, the needle component of the type III secretion apparatus from Shigella and Salmonella. Protein Sci (2006) 1.11
Conformational stability and differential structural analysis of LcrV, PcrV, BipD, and SipD from type III secretion systems. Protein Sci (2007) 1.10
A three-dimensional homology model of lipid-free apolipoprotein A-IV using cross-linking and mass spectrometry. J Biol Chem (2008) 1.10
Properties of synthetic spider silk fibers based on Argiope aurantia MaSp2. Biomacromolecules (2008) 1.08
The crystal structures of Klebsiella pneumoniae acetolactate synthase with enzyme-bound cofactor and with an unusual intermediate. J Biol Chem (2003) 1.08
The trapping of a spontaneously "flipped-out" base from double helical nucleic acids by host-guest complexation with beta-cyclodextrin: the intrinsic base-flipping rate constant for DNA and RNA. J Am Chem Soc (2002) 1.07
A rapid, three-step process for the preformulation of a recombinant ricin toxin A-chain vaccine. J Pharm Sci (2007) 1.06
Anthrax vaccine powder formulations for nasal mucosal delivery. J Pharm Sci (2006) 1.04
Influence of aggregation on immunogenicity of recombinant human Factor VIII in hemophilia A mice. J Pharm Sci (2006) 1.04
Effect of metal cations on the conformation and inactivation of recombinant human factor VIII. J Pharm Sci (2004) 1.04
Predicting residue-residue contacts using random forest models. Bioinformatics (2011) 1.02
The complex inter-relationships between protein flexibility and stability. J Pharm Sci (2008) 1.02
The structure of DNA within cationic lipid/DNA complexes. Biophys J (2003) 1.01
Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies. Biochemistry (2007) 1.01
Effects of stabilizers on the destabilization of proteins upon adsorption to aluminum salt adjuvants. J Pharm Sci (2007) 1.00
Transcription activation by the DNA-binding domain of the AraC family protein RhaS in the absence of its effector-binding domain. J Bacteriol (2007) 1.00
Identification of properties important to protein aggregation using feature selection. BMC Bioinformatics (2013) 1.00
Spectroscopic and calorimetric analyses of invasion plasmid antigen D (IpaD) from Shigella flexneri reveal the presence of two structural domains. Biochemistry (2006) 1.00
Experiments and comprehensive simulations of the formation of a helical turn. J Phys Chem B (2012) 0.99
Oligomeric states of the Shigella translocator protein IpaB provide structural insights into formation of the type III secretion translocon. Protein Sci (2013) 0.99
Effects of solutes on empirical phase diagrams of human fibroblast growth factor 1. J Pharm Sci (2007) 0.99
The reactive metabolite target protein database (TPDB)--a web-accessible resource. BMC Bioinformatics (2007) 0.99
Insulin containing polyethylenimine-dextran sulfate nanoparticles. Int J Pharm (2003) 0.99
A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. J Pharm Sci (2002) 0.99
Unassisted transport of N-acetyl-L-tryptophanamide through membrane: experiment and simulation of kinetics. J Phys Chem B (2012) 0.98
Characterization of the interaction of single tryptophan containing mutants of IpaC from Shigella flexneri with phospholipid membranes. Biochemistry (2006) 0.98
Multidimensional methods for the formulation of biopharmaceuticals and vaccines. J Pharm Sci (2011) 0.98
A novel scoring function for discriminating hyperthermophilic and mesophilic proteins with application to predicting relative thermostability of protein mutants. BMC Bioinformatics (2010) 0.98
Sequence-based source tracking of Escherichia coli based on genetic diversity of beta-glucuronidase. J Environ Qual (2004) 0.97
Are MDCK cells transfected with the human MRP2 gene a good model of the human intestinal mucosa? Pharm Res (2002) 0.96
Lipid binding region (2303-2332) is involved in aggregation of recombinant human FVIII (rFVIII). J Pharm Sci (2005) 0.96
Equilibrium structure and folding of a helix-forming peptide: circular dichroism measurements and replica-exchange molecular dynamics simulations. Biophys J (2004) 0.96
Improved data visualization techniques for analyzing macromolecule structural changes. Protein Sci (2012) 0.96
Stability of the Clostridium botulinum type A neurotoxin complex: an empirical phase diagram based approach. Mol Pharm (2007) 0.95
Trypanosoma cruzi: molecular cloning and characterization of the S-adenosylhomocysteine hydrolase. Exp Parasitol (2003) 0.94
Hydroxylation activity of P450 BM-3 mutant F87V towards aromatic compounds and its application to the synthesis of hydroquinone derivatives from phenolic compounds. Appl Microbiol Biotechnol (2004) 0.94
Structure, dynamics and interaction with kinase targets: computer simulations of calmodulin. Biochim Biophys Acta (2004) 0.94
High-throughput biophysical analysis of protein therapeutics to examine interrelationships between aggregate formation and conformational stability. AAPS J (2013) 0.94
Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release. J Pharm Sci (2011) 0.94
A systematic approach to stabilizing EBA-175 RII-NG for use as a malaria vaccine. Vaccine (2006) 0.93
Structural stability of vault particles. J Pharm Sci (2009) 0.93
Biophysical characterization of Chlamydia trachomatis CT584 supports its potential role as a type III secretion needle tip protein. Biochemistry (2009) 0.92
Contributions of active site residues to the partial and overall catalytic activities of human S-adenosylhomocysteine hydrolase. Biochemistry (2002) 0.92
Effects of pH and polyanions on the thermal stability of fibroblast growth factor 20. Mol Pharm (2007) 0.92
An empirical phase diagram approach to investigate conformational stability of "second-generation" functional mutants of acidic fibroblast growth factor-1. Protein Sci (2012) 0.92
Using empirical phase diagrams to understand the role of intramolecular dynamics in immunoglobulin G stability. J Pharm Sci (2009) 0.92
Protection of SH-SY5Y neuronal cells from glutamate-induced apoptosis by 3,6'-disinapoyl sucrose, a bioactive compound isolated from Radix Polygala. J Biomed Biotechnol (2011) 0.91
Comparative kinetics of cofactor association and dissociation for the human and trypanosomal S-adenosylhomocysteine hydrolases. 1. Basic features of the association and dissociation processes. Biochemistry (2007) 0.91
Polyvinylpyrrolidone-drug conjugate: synthesis and release mechanism. J Control Release (2004) 0.91
Parenteral immunization with IpaB/IpaD protects mice against lethal pulmonary infection by Shigella. Vaccine (2013) 0.91
Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags. J Pharm Sci (2012) 0.90
PPARβ Regulates Liver Regeneration by Modulating Akt and E2f Signaling. PLoS One (2013) 0.90
Extended calix[4]arene analogues by two P-CuI-P bridges and anion encapsulation. Inorg Chem (2006) 0.90
Isoflurane preconditioning confers cardioprotection by activation of ALDH2. PLoS One (2013) 0.90
Advances in vaccines against neglected tropical diseases: enhancing physical stability of a recombinant hookworm vaccine through biophysical and formulation studies. Hum Vaccin Immunother (2012) 0.90
Compositional effects of cationic lipid/DNA delivery systems on transgene expression in cell culture. J Pharm Sci (2004) 0.89
A biophysical characterization of the peptide drug pramlintide (AC137) using empirical phase diagrams. J Pharm Sci (2008) 0.89
Disulfide bond formation promotes the cis- and trans-dimerization of the E-cadherin-derived first repeat. J Biol Chem (2002) 0.89
Canine cathelicidin (K9CATH): gene cloning, expression, and biochemical activity of a novel pro-myeloid antimicrobial peptide. Dev Comp Immunol (2007) 0.89
Domain motions and the open-to-closed conformational transition of an enzyme: a normal mode analysis of S-adenosyl-L-homocysteine hydrolase. Biochemistry (2005) 0.89